Quest Diagnostics price target raised to $178 from $177 at Mizuho
Mizuho raised the firm’s price target on Quest Diagnostics (DGX) to $178 from $177 and keeps an Outperform rating on the shares following the ...
Zacks.com on MSN23h
Here's Why Quest Diagnostics (DGX) is a Strong Growth Stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...